PODCAST: Politicians Hate Increases in Premiums
bit.ly/4bkoqwo
Duane Schulthess Better Science Better Health VitalTransformation Douglas Holtz-Eakin American Action Forum

PODCAST: The IRA Will Cause a Sticker Shock for Premiums bit.ly/4bkoqwo
Duane Schulthess Better Science Better Health VitalTransformation Douglas Holtz-Eakin American Action Forum

PODCAST: “The Inflation Reduction Act has Terrible Terrible Incentives” bit.ly/4bkoqwo
Duane Schulthess Better Science Better Health VitalTransformation Douglas Holtz-Eakin American Action Forum

PODCAST: “Indications are going to be deeply affected by the IRA” bit.ly/4bkoqwo
Duane Schulthess Better Science Better Health VitalTransformation Douglas Holtz-Eakin American Action Forum

PODCAST: Douglas Holtz-Eakin, 'Indications are going to be deeply affected by the IRA'
bit.ly/4bkoqwo

Duane Schulthess Better Science Better Health VitalTransformation Douglas Holtz-Eakin American Action Forum

VT predicts a 78% decrease in EU biopharma startup firms over 6 years.
bit.ly/4d3NvwY

@amgen AbbVie AbbVieuk I Am Biotech Duane Schulthess Better Science Better Health VitalTransformation

According to the French Senate, the growth in clawbacks exceeds 900% since 2015.
bit.ly/4d3NvwY

@amgen AbbVie AbbVieuk I Am Biotech Duane Schulthess Better Science Better Health VitalTransformation

At current rates, EU member state clawbacks will exceed revenues by 2034.
bit.ly/4d3NvwY

@amgen AbbVie AbbVieuk I Am Biotech Duane Schulthess Better Science Better Health VitalTransformation

EU biopharma company startups declined 50% in 2018, well before the COVID pandemic #gpl
bit.ly/4d3NvwY

@amgen AbbVie AbbVieuk I Am Biotech Duane Schulthess Better Science Better Health VitalTransformation

‘Incentives’ to gain 12 years of data protection will cost -$1.2 bil in NPV #gpl
bit.ly/4d3NvwY

@amgen AbbVie AbbVieuk I Am Biotech Duane Schulthess Better Science Better Health VitalTransformation

‘Incentives’ to regain two-years of lost data protection will cost -$400 mil NPV #gpl
bit.ly/4d3NvwY

Amgen 🧪🔬🧬 AbbVie AbbVieuk I Am Biotech Duane Schulthess Better Science Better Health VitalTransformation

How detrimental is the #IRA ?

Douglas Holtz-Eakin: 'We will defer access to the most innovative therapies as a matter of course.'

Graham Cookson: 'It really cuts off the incentive to develop a follow-on indication.'

Duane Schulthess: “The [oncology] pathway is destroyed, completely.”

New study 'The EU General Pharmaceutical Legislation & Clawbacks: Calculated impacts – both designed and unintended.' bit.ly/4d3NvwY

@amgen @AbbVie I Am Biotech Duane Schulthess Better Science Better Health VitalTransformation AbbVieuk

PODCAST: Bayh-Dole Created $1 Trillion of U.S. GDP
-->bit.ly/3IXyv60

John LaMattina PureTech Forbes Duane Schulthess VitalTransformation Better Science Better Health

PODCAST: 'All these government analysis...it's just garbage'
--> bit.ly/3IXyv60

John LaMattina PureTech Forbes Duane Schulthess VitalTransformation Better Science Better Health

GetReal Institute 2024 Annual Conference: Editor’s highlights evidencebaseonline.com/getreal-instit…

John LaMattina – Drug Price Controls and IP Attacks Get Real omny.fm/shows/vital-he…
John LaMattina PureTech Forbes Duane Schulthess VitalTransformation Better Science Better Health

PODCAST: The Fact Free Attacks on IP
-->bit.ly/4cwv0Ba

Duane Schulthess Bayh-Dole Coalition VitalTransformation Better Science Better Health AAU

Douglas Holtz-Eakin U.S. CBO Kenneth Thorpe Donna Cryer Through his research and simulation with VitalTransformation, Duane Schulthess saw the CBO measured average impact — not for specific indications — in #IRA investments.

The IRA will deter investors from drug discovery in Medicare, but that’s where most value and patient need exists.

PODCAST: NIH money is dwarfed by the funding by industry --> bit.ly/48RPYY9
Duane Schulthess
Bayh-Dole Coalition
I Am Biotech
VitalTransformation
Better Science Better Health